Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Maxim Group Initiates Coverage On VSee Health with Buy Rating, Announces Price Target of $5

Author: Benzinga Newsdesk | February 24, 2025 12:11pm
Maxim Group analyst Allen Klee initiates coverage on VSee Health (NASDAQ:VSEE) with a Buy rating and announces Price Target of $5.

Posted In: VSEE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist